<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Sch of Molecular. Genetics &amp; Pop Health</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/2B7A4C97-F751-45B5-88B4-228FCEC68281"><gtr:id>2B7A4C97-F751-45B5-88B4-228FCEC68281</gtr:id><gtr:firstName>Iain</gtr:firstName><gtr:surname>Anthony</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/73D66D0E-46DF-4CE0-96A8-CFC2B6ABB896"><gtr:id>73D66D0E-46DF-4CE0-96A8-CFC2B6ABB896</gtr:id><gtr:firstName>Juan-Carlos</gtr:firstName><gtr:surname>Arango</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E56CAE96-E8B2-4100-90AC-727DC450A92D"><gtr:id>E56CAE96-E8B2-4100-90AC-727DC450A92D</gtr:id><gtr:firstName>James</gtr:firstName><gtr:otherNames>Wilson</gtr:otherNames><gtr:surname>Ironside</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/23ED1FDC-F4BC-42EC-A5C8-1B48D21124A9"><gtr:id>23ED1FDC-F4BC-42EC-A5C8-1B48D21124A9</gtr:id><gtr:firstName>Colin</gtr:firstName><gtr:surname>Smith</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/BCD2F857-3725-458E-AC6C-A46515B6EEE3"><gtr:id>BCD2F857-3725-458E-AC6C-A46515B6EEE3</gtr:id><gtr:firstName>Anthony</gtr:firstName><gtr:surname>Busuttil</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0500863"><gtr:id>22228124-986F-43ED-B2FC-B5E88E2710A8</gtr:id><gtr:title>Continuation of the Edinburgh HIV Brain &amp;amp; Tissue Resource</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0500863</gtr:grantReference><gtr:abstractText>The Edinburgh HIV Brain Bank represents a truly unique resource for research on the effects of HIV in the brain. It comprises brain and non-brain tissue samples from untreated, partially treated (Zidovudine, AZT and Didanosine, DDI) and well treated (triple therapy, HAART) HIV infected individuals, as well as from pre-AIDS individuals and age matched controls. Mortality from HIV/AIDS has fallen dramatically since the advent of HAART and most HIV-related deaths are now due to hepatitis or to drug overdose. HIV-associated dementia, HIV encephalitis and opportunistic infections are now rare but more subtle cognitive impairment remains a significant problem. We and others have recently described unexpected neuropathology findings in post-HAART cases, including levels of neuroinflammation and neurodegeneration which in some cases exceed those seen in HIV encephalitis cases. This raises concerns for the future brain health in similar individuals. Technological developments such as tissue microarray, single cell laser capture and proteomics permit novel experimental investigation of archival brain tissue samples. These two factors have lead to an increase in requests to the Edinburgh brain bank. Maintenace of this unique collection of HIV tissue samples continues to be essential for ongoing research in this field.</gtr:abstractText><gtr:technicalSummary>The Edinburgh HIV Brain Bank represents a truly unique resource comprising CNS and non-CNS tissue samples from untreated, partially treated (Zidovudine, AZT and Didanosine, DDI) and well treated (triple therapy, HAART) HIV infected individuals, as well as from clearly pre-AIDS individuals and age matched controls. Mortality from HIV/AIDS has fallen dramatically since the advent of HAART and most HIV-related deaths are now due to hepatitis or to drug overdose. HIV-associated dementia, HIV encephalitis and opportunistic infections are now rare but more subtle cognitive impairment remains a significant problem. We and others have recently described unexpected and concerning neuropathology findings in post-HAART cases, including levels of neuroinflammation and neurodegeneration which in some cases exceed those seen in HIV encephalitis cases. At the same time, technological developments such as tissue microarray, single cell laser capture and proteomics permit novel experimental investigation of archival material. These two factors have lead to an upturn in requests to the Edinburgh brain bank. Maintenace of this unique collection of HIV tissue samples continues to be essential for ongoing research in this field.</gtr:technicalSummary><gtr:fund><gtr:end>2011-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>296698</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>51D15B6F-278A-45D6-81FB-E9AD7D458E08</gtr:id><gtr:title>HIV-1-infected CD8+CD4+ T cells decay in vivo at a similar rate to infected CD4 T cells during HAART.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73f4417aa699eee44ad518534bfb9b32"><gtr:id>73f4417aa699eee44ad518534bfb9b32</gtr:id><gtr:otherNames>Hughes GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>263173DD5F7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>677A1329-C3AB-4D9F-AAA6-24882C727C9D</gtr:id><gtr:title>Impact of HIV on regional &amp;amp; cellular organisation of the brain.</gtr:title><gtr:parentPublicationTitle>Current HIV research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b86cec0b6d39932d5af0dec99ddf53b8"><gtr:id>b86cec0b6d39932d5af0dec99ddf53b8</gtr:id><gtr:otherNames>Bell JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1570-162X</gtr:issn><gtr:outcomeId>ag2wUBPnwpe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C517E361-92DA-45C8-A1DA-966EFC0F902E</gtr:id><gtr:title>Reactivation and mutation of newly discovered WU, KI, and Merkel cell carcinoma polyomaviruses in immunosuppressed individuals.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0d983303f57c39f523a562d71696766"><gtr:id>a0d983303f57c39f523a562d71696766</gtr:id><gtr:otherNames>Sharp CP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>49785D782B1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>181EB51F-0608-49CF-8657-C338A1FB1AF4</gtr:id><gtr:title>Brain protein preservation largely depends on the postmortem storage temperature: implications for study of proteins in human neurologic diseases and management of brain banks: a BrainNet Europe Study.</gtr:title><gtr:parentPublicationTitle>Journal of neuropathology and experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af057ada4257471996e8db273c713c51"><gtr:id>af057ada4257471996e8db273c713c51</gtr:id><gtr:otherNames>Ferrer I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-3069</gtr:issn><gtr:outcomeId>tLiYYdahEK8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D9233D6-D7BB-40CA-8990-ED0F16CD2811</gtr:id><gtr:title>Variation in HIV-1 R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/57bf48376dba8d4fb2f9eaa2542ba317"><gtr:id>57bf48376dba8d4fb2f9eaa2542ba317</gtr:id><gtr:otherNames>Peters PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>QBtNtZcPCP9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5032537-CED8-49E1-BF41-446EBD2291CD</gtr:id><gtr:title>Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion.</gtr:title><gtr:parentPublicationTitle>Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/43aba469a8d4344115b82265d11aee32"><gtr:id>43aba469a8d4344115b82265d11aee32</gtr:id><gtr:otherNames>Thomas ER</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0042-6822</gtr:issn><gtr:outcomeId>2E36B1E1284</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5C27A16-B6D0-45C6-8669-D508822F548D</gtr:id><gtr:title>Frequent infection of cerebellar granule cell neurons by polyomavirus JC in progressive multifocal leukoencephalopathy.</gtr:title><gtr:parentPublicationTitle>Journal of neuropathology and experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d38bf8f666d3967e99fde23e9e779eba"><gtr:id>d38bf8f666d3967e99fde23e9e779eba</gtr:id><gtr:otherNames>W?thrich C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-3069</gtr:issn><gtr:outcomeId>34F8954E4D6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3FD4BFD4-7FE5-44DC-BA47-21C7DDC20722</gtr:id><gtr:title>The effects of illicit drugs on the HIV infected brain.</gtr:title><gtr:parentPublicationTitle>Frontiers in bioscience : a journal and virtual library</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48d525a6f5eb8123cc52c6bdaebe03d3"><gtr:id>48d525a6f5eb8123cc52c6bdaebe03d3</gtr:id><gtr:otherNames>Anthony IC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1093-4715</gtr:issn><gtr:outcomeId>opW2CgMKHab</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2230693E-0A15-4A8A-B675-757473AE41BA</gtr:id><gtr:title>Accelerated Tau deposition in the brains of individuals infected with human immunodeficiency virus-1 before and after the advent of highly active anti-retroviral therapy.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48d525a6f5eb8123cc52c6bdaebe03d3"><gtr:id>48d525a6f5eb8123cc52c6bdaebe03d3</gtr:id><gtr:otherNames>Anthony IC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>3DD41C67B0E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>167BD3FA-2EC3-405E-A85B-72E7F9AF76E6</gtr:id><gtr:title>Natural resistance of human immunodeficiency virus type 1 to the CD4bs antibody b12 conferred by a glycan and an arginine residue close to the CD4 binding loop.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/273a0b8f703286629b8284751e3e9726"><gtr:id>273a0b8f703286629b8284751e3e9726</gtr:id><gtr:otherNames>Duenas-Decamp MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>kuJfNu6HLga</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0DED1395-918E-47EB-876A-FA2E4BC4D759</gtr:id><gtr:title>The Neuropathology of HIV/AIDS.</gtr:title><gtr:parentPublicationTitle>International review of psychiatry (Abingdon, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48d525a6f5eb8123cc52c6bdaebe03d3"><gtr:id>48d525a6f5eb8123cc52c6bdaebe03d3</gtr:id><gtr:otherNames>Anthony IC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0954-0261</gtr:issn><gtr:outcomeId>aWnv2AjjxqD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D230DB9C-06E2-480E-A086-4A13A478619A</gtr:id><gtr:title>Neurobiology of multiple insults: HIV-1-associated brain disorders in those who use illicit drugs.</gtr:title><gtr:parentPublicationTitle>Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b86cec0b6d39932d5af0dec99ddf53b8"><gtr:id>b86cec0b6d39932d5af0dec99ddf53b8</gtr:id><gtr:otherNames>Bell JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1557-1890</gtr:issn><gtr:outcomeId>CDB7E6BFA7D</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0500863</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>